Transmetatarsal amputation in the setting of antiphospholipid antibody syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23621979.
- Also identified by DOI 10.1053/j.jfas.2013.02.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiphospholipid syndrome is a hypercoagulable disease that can present foot and ankle surgeons with a unique challenge in treating patients who present with thrombosis and ischemia despite having normal pedal pulses. Appropriate perioperative management is imperative in these patients, because limb- and life-threatening complications can occur postoperatively, despite aggressive anticoagulation. We present the case of a 46-year-old male who underwent a transmetatarsal amputation and, despite aggressive therapy, developed a myriad of complications postoperatively. At 10 months postoperatively, the patient was doing well in an accommodative orthotic with minimal pain while receiving continued aggressive therapy and follow-up examinations by a number of specialists to treat his antiphospholipid syndrome.
Medical subject headings
- Amputation, Surgical
- Antiphospholipid Syndrome
- Arterial Occlusive Diseases
- Ischemia
- Leg Ulcer
- Lower Extremity
- Metatarsal Bones
Anatomy
- foot